US Stock MarketDetailed Quotes

CDTX Cidara Therapeutics

Watchlist

20.4000
+2.9500+16.91%

Close Nov 22 16:00 ET

21.9900
+1.5900+7.79%

Post 20:01 ET

143.75MMarket Cap-880P/E (TTM)

Cidara Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Cidara Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 0.000	--
--	2024/Q4	-- / 300.000K	--
--	2024/Q3	0.000 / 433.330K	--
--	2024/Q2	302.000K / 1.300M	--
--	2024/Q1	8.463M / 9.033M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 0.000--

--2024/Q4-- / 300.000K--

--2024/Q30.000 / 433.330K--

--2024/Q2302.000K / 1.300M--

--2024/Q18.463M / 9.033M--

Unlock Free Earnings Estimates

Open Account

Cidara Therapeutics Earnings Reports

Cidara Therapeutics | 8-K: Cidara Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results

Nov 7 22:36 ET

Cidara Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 7 16:15 ET

Cidara Therapeutics | 8-K: Cidara Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results

Aug 13 16:24 ET

Cidara Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 13 16:19 ET

Analyst Rating

Updated: Nov 8, 2024

Strong Buy

Buy
100.00%
Hold
0.00%
Sell
0.00%

Price Target

No Data

Heat List

Overall